CompletedPhase 2NCT02255032

Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious Uveitis

Studying Anterior uveitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Clearside Biomedical, Inc.
Principal Investigator
Thomas Ciulla, MD
Clearside Biomedical, Inc.
Intervention
4 mg CLS-TA(drug)
Enrollment
22 enrolled
Eligibility
18 years · All sexes
Timeline
20142016

Study locations (11)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02255032 on ClinicalTrials.gov

Other trials for Anterior uveitis

Additional recruiting or active studies for the same condition.

See all trials for Anterior uveitis

← Back to all trials